Table: Taiko Pharmaceutical -Q1 group results

Taiko Pharmaceutical

12/05/2023 07:30

May 12 (Reuters)- 
             Taiko Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2023        Mar 31, 2022     Dec 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             1.17               621 mln           7.90     
                 (+87.8 pct)                          (+56.7 pct) 
  Operating     loss 155 mln          loss 1.67         532 mln   
  Recurring     loss 242 mln          loss 1.74         60 mln    
  Net                                                   50 mln    
  Net           loss 243 mln          loss 1.75                   
  EPS           loss 5.59 yen      loss 40.13 yen      1.15 yen   
  Ann Div                                NIL                      
  -Q2 div                                NIL                      
  -Q4 div                                NIL                      
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T